A randomized trial of intravenous heparin in conjunction with anistreplase (anisoylated plasminogen streptokinase activator complex) in acute myocardial infarction: The Duke University clinical cardiology study (DUCCS) 1

Author:

O'Connor Christopher M,Meese Roderick,Carney Robert,Smith Jack,Conn Eric,Burks John,Hartman Carl,Roark Steve,Shadoff Neal,Heard Maurice,Mittler Brant,Collins Gary,Navetta Frank,Leimberger Jeff,Lee Kerry,Califf Robert M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference53 articles.

1. Guidelines for the early management of patients with acute myocardial infarction

2. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990

3. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin;Lancet,1990

4. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction;Lancet,1992

5. Randomised controlled trial of subcutaneous calcium-heparin in acute myocardial infarction;Lancet,1989

Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Heart Failure Site-Based Research in the United States;JACC: Heart Failure;2019-05

2. Improving Heart Failure Therapeutics Development in the United States;Journal of the American College of Cardiology;2018-01

3. Thrombolytic Therapy;Consultative Hemostasis and Thrombosis;2013

4. Antithrombotic Therapies for Patients with ST Segment Elevation Myocardial Infarction;Evidence‐Based Cardiology;2009-11-13

5. Antithrombin Therapy for Acute ST-Segment Elevation Myocardial Infarction;Antithrombotic Drug Therapy in Cardiovascular Disease;2009-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3